Telacebec

N/A

Report date: 2026/02/14 20:00:22
NME

Base Information

Drug NameTelacebec
Drug Alias NameImidazopyridine amideQ-203Q203
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMycobacterium tuberculosis inhibitorsBacterial growth modulatorsElectron transport complex III inhibitors
TargetsElectron transport complex III
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Tuberculosis, PulmonaryBuruli Ulcer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth AfricaAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesQurient Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma AgTb AllianceBarwon Health
Inactive CompaniesQurient Co Ltd
Active IndicationsBuruli Ulcer
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Tuberculosis, Pulmonary

Other Information

ATC CodeN/A
Related LinksN/A